Watch the full recording: https://lnkd.in/eGvBnkPk What type of deal activity do you expect to accelerate the most in 2024 and beyond? In our recent webinar, industry experts discussed the trends in deal activity for 2024 and beyond. Whether early-stage science or late-stage assets, companies are strategically navigating the market. Watch the full webinar to stay ahead of the game. #MandA #BDL #CommercialDueDiligence #IndustryInsights #Webinar James Stephanou, Calvin Fujimoto-Cassidy, Jeremy Snook, Faruk Abdullah, Andrew Therrien, Andrew Ying, CFA, MPH, Justin Averback, Kevin Yin, Srinivas Tapa, PhD, MBA, Xavier Aparicio
About us
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
- Website
-
http://eversana.com
External link for EVERSANA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Specialties
- Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global Channel Management & 3PL, Specialty Pharmacy & In-Home Nursing, HUB & Adherence Solutions, Affordability Programs, Medical Communications & Pharmacovigilance, Revenue Management, Digital Strategies & Therapy Transformation, Patient Analytics Services, Integrated Patient-Level Data, Commercial Analytics Platform, RWE & HEOR Global Services, Global Launch Expertise, and Payer Reimbursement Strategies
Locations
Employees at EVERSANA
Updates
-
Watch the full recording: https://lnkd.in/eGvBnkPk What type of deal activity do you expect to accelerate the most in 2024 and beyond? In our recent webinar, industry experts discussed the trends in deal activity for 2024 and beyond. Whether it’s early-stage science or late-stage assets, companies are strategically navigating the market. Watch the full webinar to stay ahead of the game. #MandA #BDL #CommercialDueDiligence #IndustryInsights #Webinar James Stephanou, Calvin Fujimoto-Cassidy, Jeremy Snook
-
Ready to meet the first confirmed speakers at #FH24? https://lnkd.in/daxGYDeY As the presenting sponsor, we're thrilled to see our own Jim Lang, Roberto Ascione and Alberta M.C. Spreafico, PhD, MBA will be joining fellow health leaders on stage! Frontiers Health will explore topics such as new technologies, policy, health equity and more. Join us in #Berlin! Get 20% off your tickets with code FH24EVS20!
🎉 We’re thrilled to unveil the first wave of confirmed speakers taking the stage at Frontiers Health 2024. Our speaker lineup features representatives from various sectors of the health innovation space, including industry champions, innovators, scientists, physicians, patients, investors, and CEOs of leading start-ups and scale-ups. View the list here https://lnkd.in/dyfVzDm5 They will explore our 2024 topics through inspiring plenary talks, engaging discussions, and interactive sessions, all in the true spirit of Frontiers Health. https://lnkd.in/daxGYDeY 🎟️ Don’t miss out— secure your spot now and get ready for two days filled with innovation, inspiration, and invaluable networking opportunities. Register now: https://lnkd.in/dmdSEa3Q #FH24 #Berlin #healthinnovation #lifesciences #digitalhealth #innovation #healthcare Kristin Milburn Elena Pirofalo Antonietta Pannella Luigi Pavia Giovanna D'Urso
-
Learn more: https://lnkd.in/eRVni_5s Join EVERSANA’s Mike Ryan, General Manager, Europe, at this year’s Nordic Life Science Days in Sweden on 18-19 September. Mike will be joined by industry experts to dive into the pivotal question: Are you developing a product that will reach the patient?
Patients First: The Key to Successful Commercialization in Healthcare "Organisations that effectively prioritise patient-centric thinking will be at the forefront of this new era in commercialisation." - Mike Ryan, Executive Vice President at EVERSANA The healthcare landscape is rapidly evolving, and the need to prioritize patients is no longer an afterthought. Companies that embrace patient-centric commercialization strategies will be best positioned to succeed in the global market. Join Mike and hear more about this topic during the Super Session happening on 18 Sept 11:00-12:00. Register here: https://lnkd.in/d_6sry-N
-
-
Read the blog: https://ow.ly/EUVF50SFvPq Discover the power of impactful advocacy with insights from Ryan Clarke, Senior VP of Advocacy & PR at EVERSANA. Our latest blog highlights the importance of advocacy training and how it empowers champions to drive meaningful change on important health policy issues. Learn about our comprehensive approach and how we equip advocates with the knowledge and skills needed to create lasting impact. #Advocacy #Training #MeaningfulChange #CommunityImpact
-
-
Read Now: https://lnkd.in/gR5XTrKc Incorporating AI in pharmaceutical operations is essential for staying competitive. Abid Rahman, SVP of Innovation at EVERSANA, explains how AI is revolutionizing across pharma. Dive into his Q&A on Pharmaceutical Executive. #AI #PharmaTech #EVERSANA
-
-
Download the article: https://ow.ly/4wlC50SqZ81 Stay ahead of the curve with our new article on the rise of ChatGPT-4o and the future of multi-AI agents in HEOR. Discover how these advancements are augmenting workflows and shaping the future of HEOR consulting. #AIRevolution #HEOR #ChatGPT4o Chris Cameron, Tim Disher
-
-
Read the blog: https://ow.ly/3YUZ50SErht Amish Chaturvedi recently chaired four insightful panel sessions discussing reimbursement policies at the annual #ARCS Conference in #Australia, covering key policy topics that impact the pharmaceutical, medical devices and diagnostics sectors in Australia.
-
-
Join Us at #FH24: https://lnkd.in/gqCHQkd9 Hear from Roberto Ascione, Founder & Chairman of Frontiers Health and President of Health Innovation at EVERSANA, on our pivotal role at Frontiers Health’s global conference. Use code FH24EVS20 for 20% off!
-
-
Download now: https://lnkd.in/gSWJvfE8 Check out ‘The Integral Role of Global Indirect Treatment Comparison Programs in Europe’s JCA’ by Chris Cameron, Pamela V. and Monique Martin. Learn how a global ITC program is essential for #MarketAccess and #HTA submissions. #ITC #JCA
-